Related Experiment Video
Updated: Sep 30, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Refinement of the solution structure of the heparin-binding domain of vascular endothelial growth factor using
Melissa E Stauffer1, Nicholas J Skelton, Wayne J Fairbrothe
1Department of Protein Engineering, Genentech, Inc., South, San Francisco, CA 94080, USA.
Abstract:
Previous NMR structural studies of the heparin-binding domain of vascular endothelial growth factor (VEGF165) revealed a novel fold comprising two subdomains, each containing two disulfide bridges and a short two-stranded antiparallel beta-sheet. The mutual orientation of the two subdomains was poorly defined by the NMR data. Heteronuclear relaxation data suggested that this disorder resulted from a relative lack of experimental restraints due to the limited size of the interface, rather than inherent high-frequency flexibility. Refinement of the structure using 1H(N-15N residual dipolar coupling restraints results in significantly improved definition of the relative subdomain orientations.
